U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health

Fogarty International Center

Photo of HIV infecting human cell

Focus on HIV

An estimated 40.9 million people globally are living with human immunodeficiency virus (HIV), first identified in the early 1980s. Remarkable scientific progress over four decades has led to the development of effective antiretroviral therapy (ART). In response to effective treatments and strategies, health care systems have begun to change; people living with HIV, once considered “too complex” for primary care, are returning to that setting.

Issue: July/August 2026

Global Health Matters Newsletter

NIH Websites Are Changing

NIH is moving the launch of its new website to the fall to ensure the best possible experience for everyone who relies on our websites for health information, research, funding opportunities, and other resources.

Get the Latest Updates and FAQs

Global Health Research Impacts in the U.S.

Two children playing soccer in the street

Fogarty’s Impact in Facts, Numbers, and Stories
Fogarty adds value to NIH and the Department of Health and Human Services through 439 active research and research training awards. Nearly all of Fogarty’s overseas grants involve American researchers. Two-thirds are awarded to U.S. institutions.


Close up of a tablet held by a woman in a dress

NIH-funded Global Scientific Advances Benefit the American Public
NIH-funded research conducted by U.S. and international teams in lower resource regions has led to better treatments for health challenges, including heart disease, in the United States.

Featured News

Photo of Dr. Steven Schiff (left) sitting in a chair and speaking into a microphone and Dr. Jay Bhattacharya, sitting in a chair and holding a microphone, listening to Dr. Schiff.

A LAUNCH Orientation chat reveals another side of Fogarty’s leader
At the 2026 orientation for Fogarty’s Launching Future Leaders in Global Health Research Training Program (LAUNCH), NIH Director Dr. Jay Bhattacharya discusses global research with Fogarty’s Director Dr. Steven Schiff.


Female researcher with safety glasses on, holding up and observing a vial in her green gloved hand


To reach its full potential, lenacapavir requires additional global health research
Long-acting PrEP options now include lenacapavir, widely considered an exceptional drug. It is an antiretroviral drug delivered as a shot just twice-yearly.


Global Health Fellows & Scholars

Photo of Dr. John Koethe

Nutrition and weight gain in early HIV treatment outcomes in Zambia: Dr. John Koethe, Professor, Division of Infectious Diseases, Vanderbilt University Medical Center, and Director, Tennessee Center for AIDS Research, analyzed the factors driving early mortality in HIV patients (after beginning ART) using Zambia’s National HIV Database.




Global Research In the U.S.

Headshot of Cheryl Moyer

Why being in-country matters: Benjamin Chi, MD, Department of Obstetrics and Gynecology and Department of Epidemiology at the University of North Carolina at Chapel Hill, leads a research portfolio in Zambia and neighboring countries focused on HIV care and treatment, the prevention of HIV transmission, and maternal and child health.